Julie Monnin1, Emilie Thiemard2, Pierre Vandel3, Magali Nicolier4, Gregory Tio5, Philippe Courtet6, Frank Bellivier7, Daniel Sechter8, Emmanuel Haffen9. 1. Service de Psychiatrie, Hôpital Universitaire de Besançon, 2 Place Saint Jacques, 25030 Besançon cedex, France; Université de Franche-Comté, Laboratoire de Neurosciences, EA 481, 1 Place du Maréchal Leclerc, 25030 Besançon cedex, France; Centre d'investigation clinique, Inserm CIT 808, Hôpital Universitaire de Besançon, 2 place Saint Jacques, 25030 Besançon cedex, France. Electronic address: jmonnin@chu-besancon.fr. 2. Service de Psychiatrie, Hôpital Universitaire de Besançon, 2 Place Saint Jacques, 25030 Besançon cedex, France. Electronic address: emiliethiemard@yahoo.fr. 3. Service de Psychiatrie, Hôpital Universitaire de Besançon, 2 Place Saint Jacques, 25030 Besançon cedex, France; Université de Franche-Comté, Laboratoire de Neurosciences, EA 481, 1 Place du Maréchal Leclerc, 25030 Besançon cedex, France; Centre d'investigation clinique, Inserm CIT 808, Hôpital Universitaire de Besançon, 2 place Saint Jacques, 25030 Besançon cedex, France. Electronic address: pierre.vandel@univ-fcomte.fr. 4. Service de Psychiatrie, Hôpital Universitaire de Besançon, 2 Place Saint Jacques, 25030 Besançon cedex, France. Electronic address: mnicolier@chu-besancon.fr. 5. Service de Psychiatrie, Hôpital Universitaire de Besançon, 2 Place Saint Jacques, 25030 Besançon cedex, France. Electronic address: gtio@chu-besancon.fr. 6. Département d'Urgence et Post Urgence psychiatrique, Hôpital Lapeyronie, CHRU de Montpellier, France; Université de Montpellier, Inserm U1061 Neuropsychiatrie : recherche épidémiologique et clinique, Hôpital La Colombière, Montpellier, France. Electronic address: p-courtet@chu-montpellier.fr. 7. Pôle de Psychiatrie, Hôpital Albert-Chenevier, Créteil, France; Inserm U841, Equipe 15 (Psychiatrie génétique), Faculté Henri Mondor, Créteil, France. Electronic address: frank.bellivier@inserm.fr. 8. Service de Psychiatrie, Hôpital Universitaire de Besançon, 2 Place Saint Jacques, 25030 Besançon cedex, France; Université de Franche-Comté, Laboratoire de Neurosciences, EA 481, 1 Place du Maréchal Leclerc, 25030 Besançon cedex, France; Centre d'investigation clinique, Inserm CIT 808, Hôpital Universitaire de Besançon, 2 place Saint Jacques, 25030 Besançon cedex, France. Electronic address: daniel.sechter@univ-fcomte.fr. 9. Service de Psychiatrie, Hôpital Universitaire de Besançon, 2 Place Saint Jacques, 25030 Besançon cedex, France; Université de Franche-Comté, Laboratoire de Neurosciences, EA 481, 1 Place du Maréchal Leclerc, 25030 Besançon cedex, France; Centre d'investigation clinique, Inserm CIT 808, Hôpital Universitaire de Besançon, 2 place Saint Jacques, 25030 Besançon cedex, France. Electronic address: emmanuel.haffen@univ-fcomte.fr.
Abstract
BACKGROUND: The prevention of the repetition of suicide attempts is an important feature of the care of attempters but current data fail to give actual predictors of repetition. The aim of this study was to characterize sociodemographic and psychopathological features and risk factors associated with future repetition of suicide attempts in two years. The study focused on differences between men and women. METHODS: 273 participants selected in psychiatric emergency units after their admission for a suicide attempt (index) were included in the study. Subsequent suicide attempts occurring within a two year follow-up were identified from the regional observatory of suicide attempts. At inclusion, sociodemographic variables and psychopathological data were collected. In particular, psychometric evaluations were performed using the following scales: BDI-SF, SIS, BIS and BDHI. The lifetime history of suicide attempt was also noted. RESULTS: Repetition of suicide attempt in 2 years was associated with current follow up and treatment, a personal history of multiple suicide attempt, post traumatic stress disorder, current recurrent psychotic syndrome and substance misuse. Specific features of men and women repeaters have been identified. Men repeaters were characterized by substance use disorders whereas the re-attempt in women was associated with current follow up and treatment, post traumatic stress disorder and higher BDI-SF score. CONCLUSIONS: Repeaters must be considered as a specific population among suicide attempters and gender differences must be taken into account in this particular population in order to promote more personalized prevention programs for suicidal recurrence and completed suicide.
BACKGROUND: The prevention of the repetition of suicide attempts is an important feature of the care of attempters but current data fail to give actual predictors of repetition. The aim of this study was to characterize sociodemographic and psychopathological features and risk factors associated with future repetition of suicide attempts in two years. The study focused on differences between men and women. METHODS: 273 participants selected in psychiatric emergency units after their admission for a suicide attempt (index) were included in the study. Subsequent suicide attempts occurring within a two year follow-up were identified from the regional observatory of suicide attempts. At inclusion, sociodemographic variables and psychopathological data were collected. In particular, psychometric evaluations were performed using the following scales: BDI-SF, SIS, BIS and BDHI. The lifetime history of suicide attempt was also noted. RESULTS: Repetition of suicide attempt in 2 years was associated with current follow up and treatment, a personal history of multiple suicide attempt, post traumatic stress disorder, current recurrent psychotic syndrome and substance misuse. Specific features of men and women repeaters have been identified. Men repeaters were characterized by substance use disorders whereas the re-attempt in women was associated with current follow up and treatment, post traumatic stress disorder and higher BDI-SF score. CONCLUSIONS: Repeaters must be considered as a specific population among suicide attempters and gender differences must be taken into account in this particular population in order to promote more personalized prevention programs for suicidal recurrence and completed suicide.
Authors: Cendrine Bursztein Lipsicas; Ilkka Henrik Mäkinen; Danuta Wasserman; Alan Apter; Ad Kerkhof; Konrad Michel; Ellinor Salander Renberg; Kees Van Heeringen; Airi Värnik; Armin Schmidtke Journal: Can J Psychiatry Date: 2014-10 Impact factor: 4.356
Authors: Hilario Blasco-Fontecilla; Isabelle Jaussent; Emilie Olié; Severine Béziat; Sebastien Guillaume; Paula Artieda-Urrutia; Enrique Baca-Garcia; Jose de Leon; Philippe Courtet Journal: Prim Care Companion CNS Disord Date: 2014-08-07
Authors: Christina L Boisseau; Shirley Yen; John C Markowitz; Carlos M Grilo; Charles A Sanislow; M Tracie Shea; Mary C Zanarini; Andrew E Skodol; John G Gunderson; Leslie C Morey; Thomas H McGlashan Journal: Compr Psychiatry Date: 2012-09-17 Impact factor: 3.735
Authors: Kate H Bentley; Joseph C Franklin; Jessica D Ribeiro; Evan M Kleiman; Kathryn R Fox; Matthew K Nock Journal: Clin Psychol Rev Date: 2015-12-02